INSIGHTS ON CLINICAL TRIAL DESIGN
-
How The Right Meetings Make Patient-Centered Trial Design Possible
Including patients in trial design improves recruitment, retention, and site experience. Explore practical ways sponsors can gather early input—without disrupting timelines or adding complexity.
-
How Adaptive Design Accelerates Early‑Phase NSCLC Development
Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.
-
Enhancing Clinical Trial Flexibility
Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.
-
GSK And Medable Discuss The Next Phase Of DCTs
GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
Taking A Statistics-Driven Approach To Clinical Trial Planning3/12/2025
Clinical trials are inherently complex, and even well-structured studies may struggle to achieve statistical significance due to challenges in study design, patient selection, and data variability.
-
Digital Transformation As A Foundation For Modern Chronic Disease Trials6/16/2026
Site-centric chronic trials cause patient burden. Learn how wearables and a decentralized model can shift research to continuous data capture, removing travel barriers to improve retention and disease tracking.
-
When Should You Rescue Your Clinical Trial From A Bad RTSM?4/28/2026
Stop settling for tech delays that drain your team. Learn how to evaluate a mid-study transition and implement a rescue plan that restores efficiency and control to your clinical operations.
-
Patient Trust And Engagement In The Age Of Decentralized Trials4/10/2025
To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.
-
What Does 2025 Hold For Pharma?1/17/2025
Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Advarra can serve as your partner for everything from single investigational sites to multisite research consortia and therapeutic networks.
-
Veristat has built a team of scientific-minded experts who have supported more than 300 projects for endocrine/metabolic disorder treatments and prepared over 30 marketing applications, 60% of which have been approved or authorized to date.
-
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
-
CSS offers customized patient recruitment and retention solutions across the globe, ensuring successful enrollment for clinical trials across various therapeutic areas.
-
When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.